Newbridge Financial Services Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-535
Closed -$60.7K 764
2024
Q2
$60.7K Sell
535
-1,395
-72% -$176K 0.02% 344
2024
Q1
$268K Sell
1,930
-1,134
-37% -$143K 0.12% 152
2023
Q4
$380K Buy
3,064
+132
+5% +$13.5K 0.19% 122
2023
Q3
$274K Buy
2,932
+60
+2% +$6.76K 0.14% 148
2023
Q2
$369K Sell
2,872
-215
-7% -$26K 0.18% 111
2023
Q1
$359K Sell
3,087
-195
-6% -$21.8K 0.19% 112
2022
Q4
$372K Buy
3,282
+2,770
+541% +$304K 0.21% 101
2022
Q3
$41K Hold
512
0.02% 501
2022
Q2
$38K Sell
512
-180
-26% -$16.4K 0.02% 465
2022
Q1
$89K Sell
692
-388
-36% -$42.4K 0.04% 330
2021
Q4
$145K Buy
1,080
+16
+2% +$2.3K 0.07% 244
2021
Q3
$145K Sell
1,064
-124
-10% -$15.6K 0.09% 215
2021
Q2
$127K Sell
1,188
-5,240
-82% -$503K 0.08% 239
2021
Q1
$578K Buy
6,428
+128
+2% +$12K 0.43% 51
2020
Q4
$582K Buy
6,300
+1,328
+27% +$119K 0.48% 42
2020
Q3
$512K Buy
+4,972
New +$519K 0.5% 43

Other funds holding DXCM

Newbridge Financial Services Group's DXCM Position: Q3 2024 in Review

Newbridge Financial Services Group sold out of DexCom (DXCM) in Q3 2024, closing a stake of 535 shares — an estimated $60.7K sold.

Newbridge Financial Services Group first reported a position in DXCM in Q3 2020 and held it in 16 quarters. The position peaked at $582K in Q4 2020. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Newbridge Financial Services Group reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Newbridge Financial Services Group sold 535 DexCom shares in Q3 2024, an estimated $60.7K.
  • Newbridge Financial Services Group first reported a position in DexCom in Q3 2020 and held it in 16 quarters.
  • Newbridge Financial Services Group's DexCom position peaked at $582K in Q4 2020.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Newbridge Financial Services Group's 13F filing for Q3 2024, filed 12 Nov 2024.